Jason D. Hanson
About Jason D. Hanson
Jason D. Hanson serves as the CEO and President of enGene and has held various legal and executive positions in healthcare and pharmaceuticals, including roles at GE Healthcare and Medicis Pharmaceutical Corp. He has a background in law, having worked as a prosecutor and trial attorney at the U.S. Department of Justice.
Current Role at enGene
Jason D. Hanson serves as the CEO, President, and Director at enGene since 2018. His leadership has been pivotal in guiding the company within the biotechnology sector, focusing on innovative therapeutic solutions. Under his direction, enGene has aimed to advance its mission and expand its market presence in the Greater Boston Area.
Work at Mythic Therapeutics
Hanson has held the position of Founding Director and Advisory Board Member at Mythic Therapeutics since 2018. His involvement has contributed to the strategic direction and governance of the organization, which is based in Cambridge, Massachusetts. He served on the board until 2021.
Professional Background
Hanson has extensive experience in the legal and healthcare sectors. He began his career at Arnold & Porter as an attorney from 1993 to 1997. He then worked at the U.S. Department of Justice as a prosecutor in the Antitrust Division from 1997 to 1999. His subsequent roles included senior legal positions at GE Healthcare and Medicis Pharmaceutical Corp, among others.
Education and Expertise
Hanson earned his Doctor of Law (J.D.) from Duke University School of Law, where he studied from 1991 to 1994. He also holds a Bachelor of Science (B.S.) in Economics from Cornell University, obtained from 1987 to 1991. His educational background has equipped him with a strong foundation in law and business, contributing to his expertise in corporate governance and compliance.
Previous Leadership Positions
Throughout his career, Hanson has held various leadership roles. He served as Chief Operating Officer at Medicis Pharmaceutical Corp from 2010 to 2013 and as Chief Strategy Officer at NuVasive from 2015 to 2016. His experience spans both legal and operational aspects of organizations, enhancing his strategic capabilities.